Biodistribution of nonviral cationic vector/DNA complexes was studied after systemic or intratracheal administration to the lungs and correlated with transgene expression. Intravenous injection in ...

This study evaluated Roche’s EndoCleave endonuclease against commercial benchmarks using a transient transfection platform with suspension HEK293 cells.

The global Viral Vaccines CDMO Market is set to expand from USD 2.23 billion in 2024 to USD 7.39 billion by 2033, growing at a 15.1% CAGR. This growth is fueled by rising outsourced vaccine production ...

Touchlight's enzymatic dbDNA used as a critical starting material for Versameb's VMB-100, for first-in-human clinical study to treat chronic SUI.

The market stands on the precipice of unprecedented expansion. Driven by substantial investments, groundbreaking therapeutic pipelines, and advanced technological integration, the industry is poised ...

The patented dbDNA technology produces a minimal, linear, double stranded, covalently closed DNA vector through an enzymatic manufacturing process. dbDNA is uniquely positioned for the rapid ...

Curia has enlisted enzymatic DNA production outfit Touchlight to furnish its clients with access to Touchlight’s doggybone DNA (dbDNA)—a unique DNA vector that can serve as the template for ...

Researchers found that PD-1-enhanced DNA vaccination can induce sustained virus-specific CD8+ T cell immunity in an AIDS monkey model. The vaccinated monkeys remained free of AIDS for six years ...

Many biotech and pharmaceutical companies focused on mRNA manufacturing experience challenges associated with their plasmid DNA (pDNA) supply, including slow or delayed production and poor or ...